Published in Healthcare Finance, Tax and Law Weekly, June 1st, 2005
"Our collaboration with Metabolex has been extremely productive. In less than 3 years, we have made great strides in identifying and validating several novel targets," said Isao Yanagisawa, PhD, director of Drug Discovery Research of Astellas Pharma, Inc.
"We are committed to using a genomics-based...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Healthcare Finance, Tax and Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.